Search results for: Pricing and Reimbursement
Filter search results
European Union Pharmaceutical Markets: A Case for Differential Pricing?
11 August 2015
…groups of buyers, with different abilities and willingness to pay, should efficiently be charged. From both a theoretical and a company’s decision-making perspective, the ability through pricing to allocate contributions…
Access to Orphan Drugs in the EU
21 October 2010
…determining pricing and reimbursement (P&R) also affect access. OHE’s Dr. Jorge Mestre-Ferrandiz recently presented the results of comparative research on these factors at the 9th Annual Pricing and Reimbursement Conference in…
Unlocking the Value of Combination Therapies
9 July 2024
…fairness in value attribution shares, feasibility, uncertainty of inputs and outputs, and accuracy in cases of sub- or super-additivity. IV was seen as the simplest and most feasible but insufficient…
Incorporating the Patient Voice in Health Technology Assessment
15 February 2024
…and throughout the process of drug development and evidence generation, including around defining the key trial outcomes and measures; Developers should collect and present patient evidence that complements clinical and…
Evaluating novel antimicrobials within EU joint clinical assessments
16 April 2026
…by new antimicrobials, such as reducing transmission, enabling medical procedures, and providing insurance against resistant outbreaks, are recognised and valued. The STEDI framework (spectrum, transmission, enablement, diversity, and insurance) provides…
Office of Health Economics latest research estimates 20 people a day die in unrelieved pain in the UK in the last 3 months of their lives
26 November 2024
…through pioneering and innovative research, analysis, and education. As a global thought leader and publisher in the economics of health, health care, and life sciences, we partner with Universities, Government,…
Understanding societal preferences for priority by disease severity in England & Wales
14 November 2024
…were determined, or how they may be aligned with societal preferences. We surveyed a representative sample of the population of England and Wales to understand how the public would prioritise…
Around The World in HTAs: India – Let All Be Healthy
29 June 2023
…and follow-up for most health conditions. Health Technology Assessment India (HTAIn) was established by the Ministry of Health and Family Welfare (MoHFW) in 2017 to foster transparency and evidence-based decision-making…
How Widely Are QALYs Used in OECD Countries? A Snapshot of International Practices
11 June 2025
…and cost-utility data are applied in real-world reimbursement and pricing decisions, especially when such processes are not fully structured. A table indicating the OECD countries’ classification and related sources can…